HEADER TRANSFERASE 11-JUL-23 8PQI TITLE PDGFRA T674I MUTANT KINASE DOMAIN IN COMPLEX WITH AVAPRITINIB TITLE 2 DERIVATIVE 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PDGF-R-ALPHA,PDGFR-ALPHA,ALPHA PLATELET-DERIVED GROWTH COMPND 5 FACTOR RECEPTOR,ALPHA-TYPE PLATELET-DERIVED GROWTH FACTOR RECEPTOR, COMPND 6 CD140 ANTIGEN-LIKE FAMILY MEMBER A,CD140A ANTIGEN,PLATELET-DERIVED COMPND 7 GROWTH FACTOR ALPHA RECEPTOR,PLATELET-DERIVED GROWTH FACTOR RECEPTOR COMPND 8 2,PDGFR-2; COMPND 9 EC: 2.7.10.1; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDGFRA, PDGFR2, RHEPDGFRA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PDGFRA PROTEIN KINASE, AVAPRITINIB, INHIBITOR, TYROSINE KINASE, KEYWDS 2 TRANSMEMBRANE RECEPTOR, PLATELET-DERIVED GROWTH FACTOR RECEPTOR KEYWDS 3 ALPHA, PDGF, PLATELET-DERIVED GROWTH FACTOR, GIST, GASTROINTESTINAL KEYWDS 4 STROMAL TUMORS, GATEKEEPER MUTANT, P16234, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.TEUBER,S.KLEINBOELTING,M.P.MUELLER,D.RAUH REVDAT 3 13-MAR-24 8PQI 1 REMARK REVDAT 2 17-JAN-24 8PQI 1 JRNL REVDAT 1 27-DEC-23 8PQI 0 JRNL AUTH A.TEUBER,T.SCHULZ,B.S.FLETCHER,R.GONTLA,T.MUHLENBERG, JRNL AUTH 2 M.L.ZISCHINSKY,J.NIGGENABER,J.WEISNER,S.B.KLEINBOLTING, JRNL AUTH 3 J.LATEGAHN,S.SIEVERS,M.P.MULLER,S.BAUER,D.RAUH JRNL TITL AVAPRITINIB-BASED SAR STUDIES UNVEIL A BINDING POCKET IN KIT JRNL TITL 2 AND PDGFRA. JRNL REF NAT COMMUN V. 15 63 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38167404 JRNL DOI 10.1038/S41467-023-44376-8 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 12197 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 612 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.6300 - 4.1300 1.00 3148 167 0.2026 0.2125 REMARK 3 2 4.1300 - 3.2800 0.83 2504 132 0.2425 0.2839 REMARK 3 3 3.2800 - 2.8600 0.99 2984 157 0.2840 0.3478 REMARK 3 4 2.8600 - 2.6000 1.00 2949 156 0.3184 0.3117 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.389 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.034 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 68.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 78.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2465 REMARK 3 ANGLE : 0.594 3345 REMARK 3 CHIRALITY : 0.043 361 REMARK 3 PLANARITY : 0.004 414 REMARK 3 DIHEDRAL : 14.957 886 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ( CHAIN A AND RESID 570:791 ) REMARK 3 ORIGIN FOR THE GROUP (A): 4.224 4.412 12.809 REMARK 3 T TENSOR REMARK 3 T11: 0.4141 T22: 0.4589 REMARK 3 T33: 0.4677 T12: -0.0338 REMARK 3 T13: -0.0204 T23: 0.0504 REMARK 3 L TENSOR REMARK 3 L11: 0.9703 L22: 2.2770 REMARK 3 L33: 3.2553 L12: -0.7265 REMARK 3 L13: -0.4461 L23: -0.1225 REMARK 3 S TENSOR REMARK 3 S11: -0.1405 S12: -0.1070 S13: -0.0098 REMARK 3 S21: 0.3276 S22: -0.0480 S23: -0.0021 REMARK 3 S31: 0.1036 S32: -0.0579 S33: 0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: ( CHAIN A AND RESID 792:969 ) REMARK 3 ORIGIN FOR THE GROUP (A): 5.198 3.082 -8.502 REMARK 3 T TENSOR REMARK 3 T11: 0.5486 T22: 0.5262 REMARK 3 T33: 0.4605 T12: -0.0348 REMARK 3 T13: -0.0208 T23: -0.0386 REMARK 3 L TENSOR REMARK 3 L11: 2.8570 L22: 2.1001 REMARK 3 L33: 3.2943 L12: 0.3907 REMARK 3 L13: -1.5286 L23: -0.1254 REMARK 3 S TENSOR REMARK 3 S11: -0.0741 S12: 0.0720 S13: -0.0539 REMARK 3 S21: -0.1337 S22: -0.1062 S23: 0.1307 REMARK 3 S31: 0.2406 S32: -0.3670 S33: -0.0012 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8PQI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292130428. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12552 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 46.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 13.05 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 13.54 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 MG/ML, 5% PEG3350, 200 MM KCL, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.19500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.13000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.02000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.13000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.19500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.02000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 550 REMARK 465 GLN A 551 REMARK 465 LYS A 552 REMARK 465 PRO A 553 REMARK 465 ARG A 554 REMARK 465 TYR A 555 REMARK 465 GLU A 556 REMARK 465 ILE A 557 REMARK 465 ARG A 558 REMARK 465 TRP A 559 REMARK 465 ARG A 560 REMARK 465 VAL A 561 REMARK 465 ILE A 562 REMARK 465 GLU A 563 REMARK 465 SER A 564 REMARK 465 ILE A 565 REMARK 465 SER A 566 REMARK 465 SER A 767 REMARK 465 HIS A 768 REMARK 465 LYS A 769 REMARK 465 LYS A 770 REMARK 465 LYS A 771 REMARK 465 SER A 772 REMARK 465 MET A 773 REMARK 465 LEU A 774 REMARK 465 ASP A 775 REMARK 465 SER A 776 REMARK 465 GLU A 777 REMARK 465 VAL A 778 REMARK 465 LYS A 779 REMARK 465 ASN A 780 REMARK 465 LEU A 781 REMARK 465 LEU A 782 REMARK 465 SER A 783 REMARK 465 ASP A 784 REMARK 465 ASP A 785 REMARK 465 ASN A 786 REMARK 465 SER A 787 REMARK 465 GLU A 788 REMARK 465 HIS A 845 REMARK 465 ASP A 846 REMARK 465 SER A 847 REMARK 465 ASN A 848 REMARK 465 TYR A 849 REMARK 465 VAL A 850 REMARK 465 SER A 851 REMARK 465 LYS A 852 REMARK 465 GLY A 853 REMARK 465 SER A 854 REMARK 465 LEU A 970 REMARK 465 LYS A 971 REMARK 465 SER A 972 REMARK 465 ASP A 973 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 568 CG OD1 OD2 REMARK 470 PHE A 604 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 634 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 637 CG CD OE1 OE2 REMARK 470 LYS A 638 CG CD CE NZ REMARK 470 GLN A 639 CG CD OE1 NE2 REMARK 470 LEU A 694 CG CD1 CD2 REMARK 470 MET A 844 CG SD CE REMARK 470 THR A 855 OG1 CG2 REMARK 470 GLN A 957 CG CD OE1 NE2 REMARK 470 LYS A 960 CG CD CE NZ REMARK 470 LYS A 964 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 635 -55.12 64.26 REMARK 500 ASP A 818 45.80 -150.74 REMARK 500 ASP A 836 88.22 62.52 REMARK 500 REMARK 500 REMARK: NULL DBREF 8PQI A 550 768 UNP P16234 PGFRA_HUMAN 550 696 DBREF 8PQI A 769 973 UNP P16234 PGFRA_HUMAN 769 973 SEQADV 8PQI ILE A 674 UNP P16234 THR 674 ENGINEERED MUTATION SEQRES 1 A 352 LYS GLN LYS PRO ARG TYR GLU ILE ARG TRP ARG VAL ILE SEQRES 2 A 352 GLU SER ILE SER PRO ASP GLY HIS GLU TYR ILE TYR VAL SEQRES 3 A 352 ASP PRO MET GLN LEU PRO TYR ASP SER ARG TRP GLU PHE SEQRES 4 A 352 PRO ARG ASP GLY LEU VAL LEU GLY ARG VAL LEU GLY SER SEQRES 5 A 352 GLY ALA PHE GLY LYS VAL VAL GLU GLY THR ALA TYR GLY SEQRES 6 A 352 LEU SER ARG SER GLN PRO VAL MET LYS VAL ALA VAL LYS SEQRES 7 A 352 MET LEU LYS PRO THR ALA ARG SER SER GLU LYS GLN ALA SEQRES 8 A 352 LEU MET SER GLU LEU LYS ILE MET THR HIS LEU GLY PRO SEQRES 9 A 352 HIS LEU ASN ILE VAL ASN LEU LEU GLY ALA CYS THR LYS SEQRES 10 A 352 SER GLY PRO ILE TYR ILE ILE ILE GLU TYR CYS PHE TYR SEQRES 11 A 352 GLY ASP LEU VAL ASN TYR LEU HIS LYS ASN ARG ASP SER SEQRES 12 A 352 PHE LEU SER HIS LYS LYS LYS SER MET LEU ASP SER GLU SEQRES 13 A 352 VAL LYS ASN LEU LEU SER ASP ASP ASN SER GLU GLY LEU SEQRES 14 A 352 THR LEU LEU ASP LEU LEU SER PHE THR TYR GLN VAL ALA SEQRES 15 A 352 ARG GLY MET GLU PHE LEU ALA SER LYS ASN CYS VAL HIS SEQRES 16 A 352 ARG ASP LEU ALA ALA ARG ASN VAL LEU LEU ALA GLN GLY SEQRES 17 A 352 LYS ILE VAL LYS ILE CYS ASP PHE GLY LEU ALA ARG ASP SEQRES 18 A 352 ILE MET HIS ASP SER ASN TYR VAL SER LYS GLY SER THR SEQRES 19 A 352 PHE LEU PRO VAL LYS TRP MET ALA PRO GLU SER ILE PHE SEQRES 20 A 352 ASP ASN LEU TYR THR THR LEU SER ASP VAL TRP SER TYR SEQRES 21 A 352 GLY ILE LEU LEU TRP GLU ILE PHE SER LEU GLY GLY THR SEQRES 22 A 352 PRO TYR PRO GLY MET MET VAL ASP SER THR PHE TYR ASN SEQRES 23 A 352 LYS ILE LYS SER GLY TYR ARG MET ALA LYS PRO ASP HIS SEQRES 24 A 352 ALA THR SER GLU VAL TYR GLU ILE MET VAL LYS CYS TRP SEQRES 25 A 352 ASN SER GLU PRO GLU LYS ARG PRO SER PHE TYR HIS LEU SEQRES 26 A 352 SER GLU ILE VAL GLU ASN LEU LEU PRO GLY GLN TYR LYS SEQRES 27 A 352 LYS SER TYR GLU LYS ILE HIS LEU ASP PHE LEU LYS SER SEQRES 28 A 352 ASP HET 9OO A1001 39 HET PEG A1002 7 HETNAM 9OO (1~{S})-~{N}-ETHYL-1-(4-FLUOROPHENYL)-1-[2-[4-[6-(1- HETNAM 2 9OO METHYLPYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4- HETNAM 3 9OO YL]PIPERAZIN-1-YL]PYRIMIDIN-5-YL]ETHANAMINE HETNAM PEG DI(HYDROXYETHYL)ETHER FORMUL 2 9OO C28 H31 F N10 FORMUL 3 PEG C4 H10 O3 FORMUL 4 HOH *8(H2 O) HELIX 1 AA1 ASP A 576 LEU A 580 5 5 HELIX 2 AA2 ASP A 583 GLU A 587 5 5 HELIX 3 AA3 PRO A 589 ASP A 591 5 3 HELIX 4 AA4 SER A 635 GLY A 652 1 18 HELIX 5 AA5 LEU A 682 ASN A 689 1 8 HELIX 6 AA6 THR A 791 LYS A 812 1 22 HELIX 7 AA7 PRO A 858 MET A 862 5 5 HELIX 8 AA8 ALA A 863 ASN A 870 1 8 HELIX 9 AA9 THR A 873 SER A 890 1 18 HELIX 10 AB1 ASP A 902 GLY A 912 1 11 HELIX 11 AB2 THR A 922 TRP A 933 1 12 HELIX 12 AB3 GLU A 936 ARG A 940 5 5 HELIX 13 AB4 SER A 942 LEU A 953 1 12 HELIX 14 AB5 PRO A 955 PHE A 969 1 15 SHEET 1 AA1 5 LEU A 593 SER A 601 0 SHEET 2 AA1 5 GLY A 605 TYR A 613 -1 O GLU A 609 N GLY A 596 SHEET 3 AA1 5 VAL A 621 LEU A 629 -1 O VAL A 624 N GLY A 610 SHEET 4 AA1 5 TYR A 671 GLU A 675 -1 O ILE A 672 N LYS A 627 SHEET 5 AA1 5 LEU A 660 CYS A 664 -1 N LEU A 661 O ILE A 673 SHEET 1 AA2 3 GLY A 680 ASP A 681 0 SHEET 2 AA2 3 VAL A 824 ALA A 827 -1 O LEU A 826 N GLY A 680 SHEET 3 AA2 3 ILE A 831 ILE A 834 -1 O LYS A 833 N LEU A 825 SHEET 1 AA3 2 CYS A 814 VAL A 815 0 SHEET 2 AA3 2 ARG A 841 ASP A 842 -1 O ARG A 841 N VAL A 815 CRYST1 52.390 74.040 102.260 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019088 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013506 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009779 0.00000